한글목차

수의 피부과 약품 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 95억 4,000만 달러에서 2026년에는 106억 4,000만 달러로, CAGR 11.5%로 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 동물 피부과학에 대한 낮은 인지도, 기생충 감염 발생률 증가, 기존 항진균제 및 항균제 사용, 반려동물 사육률 증가, 기초적인 외용 치료법 개발 등을 들 수 있습니다.

수의 피부과약 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 163억 7,000만 달러에 달하며, CAGR은 11.4%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 정밀 피부과 약품의 발전, 병용요법 증가, 반려동물 의료비 증가, 알레르기성 피부질환의 유병률 증가, 병원 및 소매 약국 유통 채널의 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 반려동물의 피부감염증 유병률 증가, 외용 동물용 의약품 수요 증가, 온라인 동물병원의 성장, 주사제 및 경구용 피부치료제 확대, 표적형 항기생충 치료제의 개발 등이 있습니다.

향후 수년간 반려동물을 키우는 가구 수가 증가하면서 동물용 피부과 약품 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 보호자란 반려동물을 소유하거나 보호하는 개인을 말합니다. 바쁜 일상과 사회적 고립을 극복하기 위한 반려동물 동반 욕구가 증가하면서 반려동물을 정서적 지지와 가족의 일원으로 여기는 가구가 늘어나는 것이 반려동물 양육 증가의 배경이 되고 있습니다. 동물용 피부과 의약품은 반려동물의 피부 질환을 효과적으로 치료하고, 반려동물의 편안함, 건강 상태 및 전반적인 삶의 질을 향상시켜 보호자에게 도움을 줍니다. 예를 들어 미국 비정부기구인 '쉘터 애니멀스 카운트'에 따르면 2023년 보호소와 구조단체에서 보호하던 480만 마리의 동물이 사랑스러운 가정에 입양되었다고 합니다. 따라서 반려동물 소유자 수 증가가 동물용 피부과 의약품 시장을 촉진하고 있는 것입니다.

동물용 피부과 의약품 시장의 주요 기업은 치료 효과와 편의성을 높이기 위해 야누스 키나아제(JAK) 억제제, 경구용 표적 치료제와 같은 혁신적인 치료법 개발에 집중하고 있습니다. JAK 억제제는 알레르기성 염증과 가려움증에 관여하는 세포내 신호전달 경로를 억제하는 표적치료제로, 가려움증과 긁힘의 악순환을 끊고 질환의 중증도를 감소시킵니다. 1일 1회 경구 요법은 만성 피부질환의 장기적 관리에 있으며, 복용량의 안정성과 복용의 용이성을 제공합니다. 예를 들어 2024년 9월 미국 식품의약국(FDA)은 미국에 본사를 둔 세계 동물 건강 기업 엘랑코 동물 건강(Elanco Animal Health)가 개의 알레르기 및 아토피 피부염 치료제로 젠렐리아(Zeneria, 일노시티닙 정제)를 승인했다고 발표했습니다. 1일 1회 경구용 JAK 억제제인 젠렐리아는 안전하고 높은 효능과 편의성을 겸비한 치료 옵션을 제공하며, 기존 시판 중인 제품 대비 가려움증 재발 감소 및 임상적 관해율을 개선한 것으로 나타났습니다. 이는 수의피부과 분야에서 환자 친화적인 혁신 기술에 대한 관심이 높아지고 있음을 보여줍니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Veterinary dermatology drugs are medications specifically formulated to address skin conditions in animals, such as infections, allergies, and parasites. These treatments are utilized to relieve itching, reduce inflammation, and facilitate skin healing. By addressing dermatological issues, these drugs contribute to enhancing the overall health and comfort of affected animals.

The primary categories of veterinary dermatology drugs include antifungal drugs, antibacterial drugs, and antiparasitic drugs. Antifungals are pharmaceuticals that inhibit the growth of fungi responsible for infections commonly affecting the skin, hair, and nails of animals. These drugs are administered through various routes, including topical, injectable, and oral methods. The target recipients of these medications are diverse, ranging from companion animals to livestock. The drugs are utilized for indications such as parasitic infections and allergic reactions. Distribution channels for veterinary dermatology drugs encompass retail outlets, hospital pharmacies, and online platforms.

Tariffs have impacted the veterinary dermatology drugs market by increasing the cost of imported antifungal, antibacterial, and antiparasitic drugs, particularly affecting companion animal segments in north america and europe. Segments such as topical treatments and advanced injectable formulations face higher import costs. Positive impacts include boosting domestic drug manufacturing, encouraging innovation in cost-effective formulations, and reducing dependency on global supply chains.

The veterinary dermatology drugs market research report is one of a series of new reports from The Business Research Company that provides veterinary dermatology drugs market statistics, including veterinary dermatology drugs industry global market size, regional shares, competitors with a veterinary dermatology drugs market share, detailed veterinary dermatology drugs market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary dermatology drugs industry. This veterinary dermatology drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary dermatology drugs market size has grown rapidly in recent years. It will grow from $9.54 billion in 2025 to $10.64 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to limited awareness of animal dermatology, rising incidence of parasitic infections, adoption of traditional antifungal and antibacterial drugs, growth of companion animal ownership, development of basic topical treatments.

The veterinary dermatology drugs market size is expected to see rapid growth in the next few years. It will grow to $16.37 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to advancements in precision dermatology drugs, increasing use of combination therapies, growing companion animal healthcare expenditure, rising prevalence of allergic skin conditions, expansion of hospital and retail pharmacy distribution channels. Major trends in the forecast period include rising prevalence of skin infections in companion animals, increasing demand for topical veterinary drugs, growth in online veterinary pharmacies, expansion of injectable and oral dermatology treatments, development of targeted antiparasitic therapies.

The rising number of pet owners is expected to drive growth in the veterinary dermatology drugs market in the coming years. Pet owners are individuals who own or adopt companion animals. The increase in pet ownership is fueled by a growing desire for companionship to cope with busy lifestyles and social isolation, leading more households to view pets as emotional support and family members. Veterinary dermatology drugs support pet owners by effectively treating skin conditions in their animals, improving comfort, health, and overall quality of life. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, 4.8 million animals in shelters and rescues were adopted into loving homes. Therefore, the growing number of pet owners is propelling the veterinary dermatology drugs market.

Leading players in the veterinary dermatology drugs market are focusing on developing innovative therapies, such as Janus kinase (JAK) inhibitors and targeted oral treatments, to enhance therapeutic efficacy and convenience for canine patients. JAK inhibitors are targeted therapies that block intracellular signaling pathways involved in allergic inflammation and pruritus, disrupting the itch-scratch cycle and reducing disease severity. Once-daily oral therapies provide consistent dosing and ease of administration for long-term management of chronic dermatological conditions. For instance, in September 2024, Elanco Animal Health Incorporated, a US-based global animal health company, announced that the U.S. Food and Drug Administration (FDA) approved Zenrelia (ilunocitinib tablets) for the treatment of allergic and atopic dermatitis in dogs. Zenrelia, a once-daily oral JAK inhibitor, offers a safe, highly effective, and convenient treatment option, demonstrating reduced rebound itch and improved clinical remission rates compared to existing market alternatives, highlighting the growing emphasis on targeted and patient-friendly innovations in veterinary dermatology.

In January 2023, Animal Dermatology Group, Inc., a US-based veterinary dermatology firm, acquired Golden Gate Veterinary Specialists for an undisclosed sum. This acquisition is intended to enhance Animal Dermatology Group's ability to offer specialized veterinary services by integrating Golden Gate Veterinary Specialists. This move will expand their team of over 80 veterinary specialists and reinforce their commitment to providing high-quality, individualized care in dermatology, oncology, and internal medicine to meet the increasing demand for outpatient veterinary specialty services. Golden Gate Veterinary Specialists is a US-based practice specializing in dermatological and surgical care.

Major companies operating in the veterinary dermatology drugs market are Elanco Animal Health Inc., Merck & Co. Inc., Zoetis Inc., Vetoquinol SA, Ceva Sante Animale, Virbac S.A., Bimeda Inc., IDEXX Laboratories Inc., SavaVet, Vetmedica, Mars Incorporated, Kindred Biosciences, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Nexvet, Aratana Therapeutics, Phibro Animal Health Corporation, HIPRA, Kyoritsu Seiyaku Corporation

North America was the largest region in the veterinary dermatology drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the veterinary dermatology drugs market report forecast period. The regions covered in the veterinary dermatology drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary dermatology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary dermatology drugs market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Dermatology Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary dermatology drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary dermatology drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary dermatology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Antifungal Drugs; Antibacterial Drugs; Antiparasitic Drugs
• 2) By Animal Type: Companion Animal; Livestock Animal
• 3) By Drug Indication: Parasitic Infections; Allergic Infections; Other Indications
• 4) By Route Of Administration: Topical; Injectable; Oral
• 5) By Distribution Channel: Retail; Hospital Pharmacies; Online
• Subsegments:
• 1) By Antifungal Drugs: Azoles; Polyenes; Allylamines; Echinocandins
• 2) By Antibacterial Drugs: Beta-lactams; Tetracyclines; Macrolides; Lincosamides; Aminoglycosides
• 3) By Antiparasitic Drugs: Insecticides; Anthelmintics; Topical Treatments; Systemic Treatments
• Companies Mentioned: Elanco Animal Health Inc.; Merck & Co. Inc.; Zoetis Inc.; Vetoquinol SA; Ceva Sante Animale; Virbac S.A.; Bimeda Inc.; IDEXX Laboratories Inc.; SavaVet; Vetmedica; Mars Incorporated; Kindred Biosciences; Bayer Animal Health; Boehringer Ingelheim Vetmedica; Dechra Pharmaceuticals PLC; Norbrook Laboratories Limited; Heska Corporation; Biogenesis Bago; Nexvet; Aratana Therapeutics; Phibro Animal Health Corporation; HIPRA; Kyoritsu Seiyaku Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Veterinary Dermatology Drugs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Veterinary Dermatology Drugs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Veterinary Dermatology Drugs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Veterinary Dermatology Drugs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Prevalence Of Skin Infections In Companion Animals
  • 4.2.2 Increasing Demand For Topical Veterinary Drugs
  • 4.2.3 Growth In Online Veterinary Pharmacies
  • 4.2.4 Expansion Of Injectable And Oral Dermatology Treatments
  • 4.2.5 Development Of Targeted Antiparasitic Therapies

5. Veterinary Dermatology Drugs Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals
• 5.2 Veterinary Clinics
• 5.3 Companion Animal Owners
• 5.4 Livestock Farms
• 5.5 Online Veterinary Pharmacies

6. Veterinary Dermatology Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Dermatology Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Veterinary Dermatology Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Veterinary Dermatology Drugs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Veterinary Dermatology Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Veterinary Dermatology Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Dermatology Drugs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Dermatology Drugs Market Segmentation

• 9.1. Global Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs
• 9.2. Global Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Companion Animal, Livestock Animal
• 9.3. Global Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Parasitic Infections, Allergic Infections, Other Indications
• 9.4. Global Veterinary Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Topical, Injectable, Oral
• 9.5. Global Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Retail, Hospital Pharmacies, Online
• 9.6. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antifungal Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Azoles, Polyenes, Allylamines, Echinocandins
• 9.7. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antibacterial Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Beta-lactams, Tetracyclines, Macrolides, Lincosamides, Aminoglycosides
• 9.8. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antiparasitic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Insecticides, Anthelmintics, Topical Treatments, Systemic Treatments

10. Veterinary Dermatology Drugs Market Regional And Country Analysis

• 10.1. Global Veterinary Dermatology Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Veterinary Dermatology Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Dermatology Drugs Market

• 11.1. Asia-Pacific Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Dermatology Drugs Market

• 12.1. China Veterinary Dermatology Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Dermatology Drugs Market

• 13.1. India Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Dermatology Drugs Market

• 14.1. Japan Veterinary Dermatology Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Dermatology Drugs Market

• 15.1. Australia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Dermatology Drugs Market

• 16.1. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Dermatology Drugs Market

• 17.1. South Korea Veterinary Dermatology Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Dermatology Drugs Market

• 18.1. Taiwan Veterinary Dermatology Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Dermatology Drugs Market

• 19.1. South East Asia Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Dermatology Drugs Market

• 20.1. Western Europe Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Dermatology Drugs Market

• 21.1. UK Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Dermatology Drugs Market

• 22.1. Germany Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Dermatology Drugs Market

• 23.1. France Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Dermatology Drugs Market

• 24.1. Italy Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Dermatology Drugs Market

• 25.1. Spain Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Dermatology Drugs Market

• 26.1. Eastern Europe Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Dermatology Drugs Market

• 27.1. Russia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Dermatology Drugs Market

• 28.1. North America Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Dermatology Drugs Market

• 29.1. USA Veterinary Dermatology Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Dermatology Drugs Market

• 30.1. Canada Veterinary Dermatology Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Dermatology Drugs Market

• 31.1. South America Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Dermatology Drugs Market

• 32.1. Brazil Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Dermatology Drugs Market

• 33.1. Middle East Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Dermatology Drugs Market

• 34.1. Africa Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Veterinary Dermatology Drugs Market, Segmentation By Product Type, Segmentation By Animal Type, Segmentation By Drug Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Dermatology Drugs Market Regulatory and Investment Landscape

36. Veterinary Dermatology Drugs Market Competitive Landscape And Company Profiles

• 36.1. Veterinary Dermatology Drugs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Veterinary Dermatology Drugs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Veterinary Dermatology Drugs Market Company Profiles
  • 36.3.1. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Vetoquinol SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Dermatology Drugs Market Other Major And Innovative Companies

• Virbac S.A., Bimeda Inc., IDEXX Laboratories Inc., SavaVet, Vetmedica, Mars Incorporated, Kindred Biosciences, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Nexvet, Aratana Therapeutics

38. Global Veterinary Dermatology Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Dermatology Drugs Market

40. Veterinary Dermatology Drugs Market High Potential Countries, Segments and Strategies

• 40.1 Veterinary Dermatology Drugs Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Veterinary Dermatology Drugs Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Veterinary Dermatology Drugs Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer